Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prostate Cancer Diagnosis by Multiparametric Ultrasound
NCT06024772Phase 3Not yet recruiting
- Sponsor
- Thomas Jefferson University
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Modality
- Drug Delivery Systems
- Countries
- 2
01
Overview
A Phase 3 trial of perflutren lipid microspheres in prostate cancer (PCa), sponsored by Thomas Jefferson University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
perflutren lipid microspheres
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT06024772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06024772.